FDA Orphan Drug designations – July 2014

In Regulation & Government by Cameron

FDA – 02/07/2014
Generic Name:  carbenoxolone
Trade Name:
Orphan Designation:  Treatment of Huntington’s Disease
Orphan Designation Status:  Designated
FDA Orphan Approved:  Not FDA Approved for Orphan Indication
Sponsor:  Oxalys Pharmaceuticals

Back to designations list